(KLAC) KLA - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4824801009
Stock: Inspection, Metrology, Software, Etch, Deposition
Total Rating 80
Risk 85
Buy Signal -0.08
| Risk 5d forecast | |
|---|---|
| Volatility | 47.7% |
| Relative Tail Risk | -7.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.61 |
| Alpha | 68.78 |
| Character TTM | |
|---|---|
| Beta | 2.153 |
| Beta Downside | 1.137 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.95% |
| CAGR/Max DD | 1.65 |
EPS (Earnings per Share)
Revenue
Description: KLAC KLA March 04, 2026
KLA Corporation (KLAC) provides process control and yield management solutions to the semiconductor and electronics industries.
The company operates in three segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB and Component Inspection. KLAs offerings include inspection and metrology tools for wafer defect analysis and measurement, chemical process control equipment, and semiconductor software solutions. The semiconductor equipment sector is characterized by high capital expenditures and a cyclical demand pattern.
KLA also supplies etch, plasma dicing, and deposition technologies, alongside solutions for the PCB market and semiconductor packaging. The PCB market is a critical component in nearly all electronic devices.
For more detailed financial analysis, ValueRay can provide further insights into KLACs performance.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 4.56b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 3.78 > 1.0 |
| NWC/Revenue: 55.32% < 20% (prev 51.98%; Δ 3.35% < -1%) |
| CFO/TA 0.29 > 3% & CFO 4.77b > Net Income 4.56b |
| Net Debt (3.83b) to EBITDA (5.91b): 0.65 < 3 |
| Current Ratio: 2.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (132.2m) vs 12m ago -1.64% < -2% |
| Gross Margin: 61.89% > 18% (prev 0.60%; Δ 6129 % > 0.5%) |
| Asset Turnover: 80.35% > 50% (prev 72.26%; Δ 8.09% > 0%) |
| Interest Coverage Ratio: 19.31 > 6 (EBITDA TTM 5.91b / Interest Expense TTM 285.8m) |
Altman Z'' 6.17
| A: 0.42 (Total Current Assets 11.03b - Total Current Liabilities 3.98b) / Total Assets 16.72b |
| B: 0.17 (Retained Earnings 2.86b / Total Assets 16.72b) |
| C: 0.35 (EBIT TTM 5.52b / Avg Total Assets 15.86b) |
| D: 0.49 (Book Value of Equity 5.47b / Total Liabilities 11.25b) |
| Altman-Z'' Score: 6.17 = AAA |
Beneish M -3.18
| DSRI: 0.74 (Receivables 2.17b/2.49b, Revenue 12.74b/10.84b) |
| GMI: 0.97 (GM 61.89% / 60.28%) |
| AQI: 0.95 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 1.18 (Revenue 12.74b / 10.84b) |
| TATA: -0.01 (NI 4.56b - CFO 4.77b) / TA 16.72b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of KLAC shares?
As of March 06, 2026, the stock is trading at USD 1429.36 with a total of 1,046,424 shares traded.
Over the past week, the price has changed by -6.23%, over one month by +7.53%, over three months by +17.85% and over the past year by +101.20%.
Over the past week, the price has changed by -6.23%, over one month by +7.53%, over three months by +17.85% and over the past year by +101.20%.
Is KLAC a buy, sell or hold?
KLA has received a consensus analysts rating of 3.96.
Therefore, it is recommended to buy KLAC.
- StrongBuy: 11
- Buy: 6
- Hold: 10
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KLAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1666.7 | 16.6% |
| Analysts Target Price | 1666.7 | 16.6% |
KLAC Fundamental Data Overview March 06, 2026
P/E Trailing = 42.9168
P/E Forward = 31.348
P/S = 15.2161
P/B = 34.5658
P/EG = 1.7945
Revenue TTM = 12.74b USD
EBIT TTM = 5.52b USD
EBITDA TTM = 5.91b USD
Long Term Debt = 5.89b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 6.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.83b USD (from netDebt column, last quarter)
Enterprise Value = 195.00b USD (193.92b + Debt 6.28b - CCE 5.21b)
Interest Coverage Ratio = 19.31 (Ebit TTM 5.52b / Interest Expense TTM 285.8m)
EV/FCF = 44.53x (Enterprise Value 195.00b / FCF TTM 4.38b)
FCF Yield = 2.25% (FCF TTM 4.38b / Enterprise Value 195.00b)
FCF Margin = 34.36% (FCF TTM 4.38b / Revenue TTM 12.74b)
Net Margin = 35.76% (Net Income TTM 4.56b / Revenue TTM 12.74b)
Gross Margin = 61.89% ((Revenue TTM 12.74b - Cost of Revenue TTM 4.86b) / Revenue TTM)
Gross Margin QoQ = 61.45% (prev 61.27%)
Tobins Q-Ratio = 11.66 (Enterprise Value 195.00b / Total Assets 16.72b)
Interest Expense / Debt = 1.11% (Interest Expense 69.7m / Debt 6.28b)
Taxrate = 13.88% (184.6m / 1.33b)
NOPAT = 4.75b (EBIT 5.52b * (1 - 13.88%))
Current Ratio = 2.77 (Total Current Assets 11.03b / Total Current Liabilities 3.98b)
Debt / Equity = 1.15 (Debt 6.28b / totalStockholderEquity, last quarter 5.47b)
Debt / EBITDA = 0.65 (Net Debt 3.83b / EBITDA 5.91b)
Debt / FCF = 0.87 (Net Debt 3.83b / FCF TTM 4.38b)
Total Stockholder Equity = 4.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 28.74% (Net Income 4.56b / Total Assets 16.72b)
RoE = 95.22% (Net Income TTM 4.56b / Total Stockholder Equity 4.79b)
RoCE = 51.71% (EBIT 5.52b / Capital Employed (Equity 4.79b + L.T.Debt 5.89b))
RoIC = 44.54% (NOPAT 4.75b / Invested Capital 10.67b)
WACC = 12.68% (E(193.92b)/V(200.21b) * Re(13.06%) + D(6.28b)/V(200.21b) * Rd(1.11%) * (1-Tc(0.14)))
Discount Rate = 13.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.50%
[DCF] Terminal Value 67.30% ; FCFF base≈3.97b ; Y1≈4.84b ; Y5≈7.99b
[DCF] Fair Price = 495.5 (EV 68.78b - Net Debt 3.83b = Equity 64.95b / Shares 131.1m; r=12.68% [WACC]; 5y FCF grow 23.25% → 2.90% )
EPS Correlation: 75.17 | EPS CAGR: 15.65% | SUE: 0.29 | # QB: 0
Revenue Correlation: 73.22 | Revenue CAGR: 10.23% | SUE: 1.31 | # QB: 6
EPS current Year (2026-06-30): EPS=36.45 | Chg7d=-0.003 | Chg30d=+0.376 | Revisions Net=+18 | Growth EPS=+9.5% | Growth Revenue=+9.9%
EPS next Year (2027-06-30): EPS=46.27 | Chg7d=-0.052 | Chg30d=+1.877 | Revisions Net=+19 | Growth EPS=+27.0% | Growth Revenue=+19.0%
[Analyst] Revisions Ratio: +0.64 (23 Up / 5 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 10.7% (Discount Rate 13.1% - Earnings Yield 2.3%)
[Growth] Growth Spread = +8.3% (Analyst 19.0% - Implied 10.7%)
P/E Forward = 31.348
P/S = 15.2161
P/B = 34.5658
P/EG = 1.7945
Revenue TTM = 12.74b USD
EBIT TTM = 5.52b USD
EBITDA TTM = 5.91b USD
Long Term Debt = 5.89b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 6.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.83b USD (from netDebt column, last quarter)
Enterprise Value = 195.00b USD (193.92b + Debt 6.28b - CCE 5.21b)
Interest Coverage Ratio = 19.31 (Ebit TTM 5.52b / Interest Expense TTM 285.8m)
EV/FCF = 44.53x (Enterprise Value 195.00b / FCF TTM 4.38b)
FCF Yield = 2.25% (FCF TTM 4.38b / Enterprise Value 195.00b)
FCF Margin = 34.36% (FCF TTM 4.38b / Revenue TTM 12.74b)
Net Margin = 35.76% (Net Income TTM 4.56b / Revenue TTM 12.74b)
Gross Margin = 61.89% ((Revenue TTM 12.74b - Cost of Revenue TTM 4.86b) / Revenue TTM)
Gross Margin QoQ = 61.45% (prev 61.27%)
Tobins Q-Ratio = 11.66 (Enterprise Value 195.00b / Total Assets 16.72b)
Interest Expense / Debt = 1.11% (Interest Expense 69.7m / Debt 6.28b)
Taxrate = 13.88% (184.6m / 1.33b)
NOPAT = 4.75b (EBIT 5.52b * (1 - 13.88%))
Current Ratio = 2.77 (Total Current Assets 11.03b / Total Current Liabilities 3.98b)
Debt / Equity = 1.15 (Debt 6.28b / totalStockholderEquity, last quarter 5.47b)
Debt / EBITDA = 0.65 (Net Debt 3.83b / EBITDA 5.91b)
Debt / FCF = 0.87 (Net Debt 3.83b / FCF TTM 4.38b)
Total Stockholder Equity = 4.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 28.74% (Net Income 4.56b / Total Assets 16.72b)
RoE = 95.22% (Net Income TTM 4.56b / Total Stockholder Equity 4.79b)
RoCE = 51.71% (EBIT 5.52b / Capital Employed (Equity 4.79b + L.T.Debt 5.89b))
RoIC = 44.54% (NOPAT 4.75b / Invested Capital 10.67b)
WACC = 12.68% (E(193.92b)/V(200.21b) * Re(13.06%) + D(6.28b)/V(200.21b) * Rd(1.11%) * (1-Tc(0.14)))
Discount Rate = 13.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.50%
[DCF] Terminal Value 67.30% ; FCFF base≈3.97b ; Y1≈4.84b ; Y5≈7.99b
[DCF] Fair Price = 495.5 (EV 68.78b - Net Debt 3.83b = Equity 64.95b / Shares 131.1m; r=12.68% [WACC]; 5y FCF grow 23.25% → 2.90% )
EPS Correlation: 75.17 | EPS CAGR: 15.65% | SUE: 0.29 | # QB: 0
Revenue Correlation: 73.22 | Revenue CAGR: 10.23% | SUE: 1.31 | # QB: 6
EPS current Year (2026-06-30): EPS=36.45 | Chg7d=-0.003 | Chg30d=+0.376 | Revisions Net=+18 | Growth EPS=+9.5% | Growth Revenue=+9.9%
EPS next Year (2027-06-30): EPS=46.27 | Chg7d=-0.052 | Chg30d=+1.877 | Revisions Net=+19 | Growth EPS=+27.0% | Growth Revenue=+19.0%
[Analyst] Revisions Ratio: +0.64 (23 Up / 5 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 10.7% (Discount Rate 13.1% - Earnings Yield 2.3%)
[Growth] Growth Spread = +8.3% (Analyst 19.0% - Implied 10.7%)